broadly speaking, the chinese medicine industry includes three major parts: chinese medicinal materials, chinese medicinal pieces, and chinese patent medicines. chinese medicinal pieces are in the middle link of the chinese medicine industry and play a role in the traditional chinese medicine industry.
a series of policies to guide and encourage chinese medicine issued at the national and local levels, such as adjusting the price policy of chinese medicine medical service, and improving the service capacity of grassroots chinese medicine, encourage chinese medical institutions to give full play to the characteristics of traditional chinese medicine from different perspectives.
what is more noteworthy is that under the general environment of my country’s promotion of medical price reform in public hospitals, cancellation of drug additions, and "zero-addition" of chemical drugs and proprietary chinese medicines, the sales of chinese herbal medicines still enjoy the drug addition policy, which has become the sales of chinese herbal medicines. motivation for promotion.
recently, the state administration of traditional chinese medicine, the national health and family planning commission, the ministry of human resources and social security, the state food and drug administration, and the central military commission’s logistics support department jointly formulated and released the "thirteenth five-year plan of action for the improvement of basic-level traditional chinese medicine service capability project". , it is even more clear-the addition of chinese herbal medicine pieces will not be cancelled, and chinese herbal medicine pieces will not be included in the control scope of "drug proportion".
a. trend market position continues to improve
according to the national bureau of statistics, from 2006 to 2015, the main business income of enterprises above designated size in the pharmaceutical industry increased from 534.57 billion yuan to 2688.52 billion yuan, with a compound annual growth rate (cagr) of 19.7%; from the perspective of the pharmaceutical industry's sub-sectors , the main business income of the processing of traditional chinese medicine decoction pieces increased from 19.02 billion yuan to 16.99.9 billion yuan, and the cagr was 27.6%. the annual compound growth rate of the processing market of traditional chinese medicine decoction pieces was significantly higher than the overall growth rate of the pharmaceutical industry.
with the continuous improvement of the tcm medical service system, the market position of the tcm decoction pieces industry in the pharmaceutical manufacturing industry is constantly strengthening. from the perspective of the horizontal comparison of the sub-industry of the pharmaceutical industry in the past three years, the growth rate of the chinese herbal medicine processing industry ranks first in the eight sub-industries. from the perspective of the proportion of the main business income of the traditional chinese medicine decoction pieces industry in the main business income of the pharmaceutical manufacturing industry, in recent years, it has basically maintained an upward trend year by year.
in 2015, the total profits of enterprises above designated size in the pharmaceutical industry reached 276.823 billion yuan, a year-on-year increase of 12.22%, 14.52 percentage points higher than the national industrial growth rate, and a decrease of 0.93 percentage points from the previous year. among them, the annual profit growth rate of the chinese herbal medicine processing industry was higher than the profit growth rate of the eight sub-sectors.
in recent years, my country's pharmaceutical industry has developed rapidly, and this development momentum will continue. mainly benefit from population aging, urbanization, etc. with the continuous improvement of the industrial policy environment and the continuous expansion of market demand, the future development of the traditional chinese medicine decoction piece industry will be very broad.
b. industry challenges there is a lot of room for industrial upgrading
at present, the market capacity of the traditional chinese medicine decoction pieces industry is continuously increasing, and the traditional chinese medicine decoction pieces industry and the traditional chinese medicine decoction pieces processing industry have entered a new period of comprehensive and rapid development.
the national policy orientation has brought room for upgrading of the traditional chinese medicine decoction pieces industry, and at the same time, the development of the traditional chinese medicine decoction pieces industry is also facing many challenges.
rising prices of chinese medicinal materials: prevention and control of blind production and over-planting
overall, the market demand for chinese herbal medicines is still growing. according to the comprehensive index of the world of chinese medicinal materials, the price index value of chinese medicinal materials on august 1, 2016 was 2408.74, while on august 1, 2007, the price index value was 1218.79, with a compound growth rate (cagr) of 7.86%.
in order to prevent the blind effect of production caused by market price fluctuations, it is recommended that government departments analyze the historical prices and trends of chinese medicinal materials, predict price changes in the planting cycle, and guide planting varieties and quantities. one-sided encouragement of farmers to plant should be avoided, while ignoring the balanced development of the industrial chain.
in terms of policies, on april 27, 2015, the general office of the state council forwarded the ministry of industry and information technology, the state administration of traditional chinese medicine and other departments to issue the "protection and development plan for chinese medicinal materials (2015-2020)" to protect and protect the resources of chinese medicinal materials. the development of the chinese herbal medicine industry is fully deployed. this is my country's first national plan for the protection and development of chinese medicinal materials. the plan specifically proposes to "establish a price formation mechanism for chinese medicinal materials that reflects production and operation costs, market supply and demand, and resource scarcity."
improve industry standards: pay attention to the processing process of decoction pieces
chinese herbal medicine pieces are between chinese herbal medicines and chinese patent medicines. after the chinese medicine is processed, the components contained in it will undergo different changes due to the processing of temperature, time, solvents and different excipients. although the effective ingredients of most chinese medicinal materials are not very clear at present, people have realized from practice that the chemical components that may play a physiological role in chinese medicinal materials are mainly alkaloids, glycosides, volatile oils, resins, organic acids, and oils. , inorganic salts and other types of ingredients. processing is to retain the therapeutic ingredients, make the medicinal materials pure, change the properties of the medicine, and reduce toxicity and side effects.
chinese medicines that come into contact with chinese medicine hospitals and chinese medicine museums are processed and concocted pieces of chinese medicines. therefore, standardizing the processing process of traditional chinese medicine is the fundamental guarantee for improving the quality of traditional chinese medicine and the effectiveness of traditional chinese medicine.
c. opportunity and strategy picture 2.png
1. the whole chain model of planting, processing, and research and development
the processing of chinese herbal medicine pieces refers to the processing and treatment of natural or artificially planted and cultivated animals and plants and chinese herbal medicines. including the processing and processing of various chinese medicinal materials and the processing of chinese medicinal pieces and other extracted chinese medicinal materials.
it is precisely because its raw materials are produced under natural conditions, it is difficult to quantitatively control it manually, which is different from the quality characteristics of chemical drugs. therefore, it is necessary to establish a gap planting, processing, and research and development base for chinese medicinal materials, and to develop new technologies for extracting and extracting the effective ingredients of chinese medicinal materials to obtain a stable, reliable and traceable source of chinese medicinal materials.
this whole industry chain model not only helps standardize planting, improves the quality of chinese medicinal materials, but also protects the species diversity of chinese medicinal materials. at the same time, standardizing industry access standards can also consolidate and protect the core competition barriers of enterprises themselves.
2, "internet " hospital terminal service extension
using the internet and the internet of things (lot) combined platform to explore and practice traditional medical logistics, it can bring safer and more efficient extended services to medical terminals and patients. for example, decoction of chinese herbal medicines, ointment preparation, personalized processing of chinese herbal medicines, delivery of medicines and other services.
